A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2006
10/26/2006	US20060239936 Delivery of anti-migraine compounds through an inhalation route
10/26/2006	US20060239935 Compositions for inhalation
10/26/2006	US20060239934 Superior control of blood glucose in diabetes treatment
10/26/2006	US20060239933 Medical product
10/26/2006	US20060239932 Pharmaceutical formulations comprising magnesium stearate
10/26/2006	US20060239931 Pharmaceutical aerosol composition
10/26/2006	US20060239930 Process for nebulizing aqueous compositions containing highly concentrated insulin
10/26/2006	US20060239927 Drug for airway administration
10/26/2006	US20060239925 Method of manufacturing pharmaceutical preparation containing liposomes
10/26/2006	US20060239924 Carrier with a metal binding domain, a metal ion, and an active agent; e.g., polylysine with a polyoxyethylene side chain with a polyalkylenepolyaminepolyacetic acid bonded to a transition metal ion bonded to a protein or nucleotide; drug delivery
10/26/2006	US20060237866 Method and apparatus for preparing nanoparticles
10/26/2006	US20060237865 Microencapsulation System and Method
10/26/2006	US20060237004 Methods for treating trigeminal neuralgia
10/26/2006	US20060237003 Methods for treating headaches
10/26/2006	DE20321278U1 Cosmetic or dermatological preparation in water-in-oil emulsion form, useful to treat e.g. neurodermatitis, dyskeratoses and scars, comprises phytosterols and optionally additional materials
10/26/2006	DE20321277U1 Cosmetic/dermatological preparation in form of oil-in water emulsion, useful for treating e.g. neurodermatitis and skin aging, comprises phytosterol groups, oil components and additional materials
10/26/2006	DE102005017985A1 Accelerated dissolving of dry pharmaceutical products for injection, comprises locking filled active substance container under vacuum with plug, durably storing substance, adding liquid to substance, mixing and dissolving substance
10/26/2006	DE102005016102B3 Vorrichtung zur Dosierung und Trockenvernebelung Device for dosing and dry nebulization
10/26/2006	DE102005016100B3 Vorrichtung zur Dosierung und Trockenvernebelung Device for dosing and dry nebulization
10/26/2006	DE10163667B4 Verwendung von Desoxypeganin zur Behandlung der klinischen Depression Use of deoxypeganine for the treatment of clinical depression
10/26/2006	CA2675652A1 Dosage forms of risedronate
10/26/2006	CA2606224A1 External preparation, method of applying external preparation, iontophoresis device, and percutaneous patch
10/26/2006	CA2606207A1 Pharmaceutical composition
10/26/2006	CA2605183A1 Bioenhanced compositions
10/26/2006	CA2605180A1 Controlled delivery dosage form of tramadol and gabapentin
10/26/2006	CA2604431A1 Method of increasing testosterone and related steroid concentrations in women
10/26/2006	CA2604281A1 Nanoparticulate and controlled release compositions comprising prostaglandin derivatives
10/26/2006	CA2574572A1 Modulation of cytokine signaling regulators and applications for immunotherapy
10/25/2006	EP1715035A2 Synthetic polynucleotides encoding lysyl oxidase
10/25/2006	EP1714988A1 High-strength tablet binders based on finely divided vinyllactam polymers, their preparation and use
10/25/2006	EP1714977A2 Synthesis of cyclosporin analogs
10/25/2006	EP1714969A2 Immunostimulatory nucleic acid molecules
10/25/2006	EP1714657A1 Solid formulation for dialysis and process for producing the same
10/25/2006	EP1714656A1 Ed-71 preparation
10/25/2006	EP1714653A1 Aqueous solution preparation containing camptothecins
10/25/2006	EP1714649A2 L-Valine for hepatic diseases
10/25/2006	EP1714643A1 Sustained release preparation
10/25/2006	EP1714642A1 Pharmaceutical composition comprising gas-filled microcapsules for ultrasound mediated delivery
10/25/2006	EP1714641A2 Osmotic device containing a venlafaxine salt and a salt having a common ion
10/25/2006	EP1713575A1 Aqueous dispersion and its use
10/25/2006	EP1713521A2 Haemostatic sprays and compositions
10/25/2006	EP1713514A2 Drugs and gene carrier particles that rapidly move through mucous barriers
10/25/2006	EP1713506A1 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
10/25/2006	EP1713505A1 Method of preparation of a fungal glucane hydrogel having antibacterial and immunostimulant activity, and use thereof
10/25/2006	EP1713504A2 Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
10/25/2006	EP1713502A1 Highly concentrated liquid formulations of anti-egfr antibodies
10/25/2006	EP1713498A1 Composition comprising polymeric material and uses thereof
10/25/2006	EP1713492A1 Effervescent composition including cranberry extract
10/25/2006	EP1713485A2 Treatment of degenerative cartilage conditions in a mammal with glycosidase inhibitors
10/25/2006	EP1713476A2 Rabeprazole containing formulation
10/25/2006	EP1713471A2 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
10/25/2006	EP1713469A1 Hypocholesterolemic compositions comprising a statin and an antiflatulent agent
10/25/2006	EP1713468A1 Anthelmintic composition
10/25/2006	EP1713466A2 Antiparasitic composition containing an organic amine salt of closantel
10/25/2006	EP1713456A1 Rectal composition
10/25/2006	EP1713454A1 Enteric delivery of (-)-hydroxycitric acid
10/25/2006	EP1713453A2 Implantable drug delivery device including wire filaments
10/25/2006	EP1713452A2 Sustained release pharmaceutical composition of indapamide
10/25/2006	EP1713451A1 Solid dosage formulations of galanthamine
10/25/2006	EP1713450A1 Rapidly dissolving film for delivery of an active agent
10/25/2006	EP1713448A1 Stable beadlets of lipophilic nutrients
10/25/2006	EP1713447A1 Particulate plant sterol compositions
10/25/2006	EP1713446A2 Ternary non-lamellar lipid compositions
10/25/2006	EP1713445A2 Non-lamellar compositions of dioleoyl phosphatidylethanolamine and polysorbate 80
10/25/2006	EP1713444A1 A microemulsion preparation of high concentration propofol for anesthetic uses
10/25/2006	EP1713443A2 Nanosuspensions of anti-retroviral agents for increased central nervous system delivery
10/25/2006	EP1713442A1 Semisolid matrix pharmaceutical formulations
10/25/2006	EP1713441A2 Interleukin-13 antagonist powders, spray-dried particles, and methods
10/25/2006	EP1713440A2 Engineered proteins, and methods of making and using
10/25/2006	EP1713439A1 Pharmaceutical preparation for the oral cavity
10/25/2006	EP1638527B1 Composite product obtainable by cogrinding of an active principle with a copolymer n-vinyl-2-pyrrolidone/vinyl-acetate
10/25/2006	EP1524971B1 Improved transdermal delivery system
10/25/2006	EP1490030B1 Nanoparticulate compositions of angiogenesis inhibitors
10/25/2006	EP1420880A4 Stabilization and terminal sterilization of phospholipid formulations
10/25/2006	EP1377275B1 Vaccine for modulating between t1 and t2 immune responses
10/25/2006	EP1363951B1 Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
10/25/2006	EP1261470B1 Method and apparatus for blowmolding capsules of polyvinylalcohol and blowmolded polyvinylalcohol capsules
10/25/2006	EP1259250B1 Endoparasiticidal agents
10/25/2006	EP1143930B1 Pharmaceutical formulation of fluticasone propionate
10/25/2006	EP1115454B1 Controlled dosage drug delivery system
10/25/2006	EP1105110B1 Spray on bandage and drug delivery system
10/25/2006	EP1079811B1 Biodegradable sustained-release alginate gels
10/25/2006	EP0983088B1 Immunpotentiating composition in a solid dosage form, having collagen or polydimethylsiloxane as a carrier substance
10/25/2006	CN2829774Y Medicinal umbilical patch for treating diabetes
10/25/2006	CN2829741Y Wet dressing medicinal napkin for skin disease
10/25/2006	CN2829443Y Face beauty film with earmuff
10/25/2006	CN1853156A Ergonomic pointing device
10/25/2006	CN1852862A Calcium phosphate granules of hydroxyapatite, preparation and use of the same
10/25/2006	CN1852743A Methods and devices for the treatment of intervertebral discs
10/25/2006	CN1852739A Pharmaceutical products comprising bisphosphonates
10/25/2006	CN1852727A Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives
10/25/2006	CN1852711A Infection prophylaxis using immune response modifier compounds
10/25/2006	CN1852705A Methods and compositions for delivery of catecholic butanes for treatment of obesity
10/25/2006	CN1852703A Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
10/25/2006	CN1852702A Sterile preparations of phospholipids and anti-inflammatory pharmaceuticals and methods for making and using same
10/25/2006	CN1852701A Method and apparatus for preventing allergies
10/25/2006	CN1852700A Triamcinolone acetonide and anecortave acetate formulations for injection
10/25/2006	CN1852690A Medicament conveying system
10/25/2006	CN1852687A Method for the preparation of controlled release formulations
10/25/2006	CN1850826A Eremophil dilactone natural product with tumour cell growth inhibiting activity

1 ... 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 ... 2991